Fascioliasis is one of the most important zoonotic diseases of sheep and cattle. The disease has a cosmopolitan distribution, being prevalent in most sheep-raising countries. Human fascioliasis has been reported in many countries, including Iran. In 1989, an outbreak of human fascioliasis was reported from Guilan province in the north of Iran (Caspian Sea littoral). More than 10,000 individuals were reported infected in the area, which is still considered endemic for fascioliasis.[@b1-asm-1-18] Human cases are reported frequently.

Both stool examination and serological methods are applied in the diagnosis of fascioliasis. The diagnosis of human fascioliasis based on the detection of the parasite ova in stool is often unreliable because a) egg deposition of the parasite is not regular, b) the incubation phase of the infection is shorter than that of the prepatent period, and c) clinical findings of the disease may appear long before egg can be found in stools.[@b2-asm-1-18] Thus, various serodiagnostic techniques such as immunofluorescent assay (IFA), indirect hemagglutination (IHA), enzyme-linked immunosorbent assay (ELISA) and Dot-ELISA have been developed for diagnosis of human fascioliasis in different laboratories. Unlike IFA and IHA,[@b2-asm-1-18] ELISA is highly sensitive and specific.[@b3-asm-1-18]--[@b5-asm-1-18] The disadvantage of ELISA technique for field studies is the requirement for a spectrophotometer, whereas most serological tests can be performed easily in the field. A spectrophotometer is not required with Dot-ELISA, a modification of ELISA technique. The Dot-ELISA test has been evaluated for the immune diagnosis of animal or human fascioliasis using different antigens.[@b6-asm-1-18],[@b7-asm-1-18] We evaluated the partially purified fraction (PPF) antigen extracted from adult *Fasciola gigantica* for the serodiagnosis of human fascioliasis using Dot-ELISA technique.

Materials and Methods
=====================

The methods of Hillyer and de Weil [@b8-asm-1-18] and Mansour et al. [@b9-asm-1-18] were used for preparation of partially purified *Fasciola gigantica* antigen. Briefly, adult *Fasciola gigantica* were collected from the infected livers of sheep slaughtered at an abattoir. The parasites were washed three times with phosphate-buffered saline (PBS), homogenized and centrifuged at 5×10^4^ g for 1 hour at 4°C. The protein content of the supernatant was measured by the Lowry et al.[@b10-asm-1-18] method. Thirty milligrams of the soluble antigen were loaded on a G-200 Sephadex column, then eluted with 0.1 M PBS, pH 7.4. Four milliliters of fractions were collected and their absorbances were measured at 280 nm. Fractions from peak II and III were pooled and dialyzed against TBS (Tris-Buffered Saline) at 4°C and their protein contents were measured and stored at −20°C until used. The method of Zimmerman et al [@b11-asm-1-18] was used for preparation of E/S (excretory/secretory) antigen from *Fasciola gigantica.*

We collected 261 sera from three groups. The first group consisted of 104 patients from Anzali city, Guilan province, North Iran, an area endemic for human fascioliasis. The patients had clinical symptoms of fasciolias is, passed *Fasciola* eggs in their faeces and had a positive ELISA test. The second group consisted of 89 non-fascioliasis patients from a non-endemic area (Tehran) who were negative in a 3-stool examination and ELISA test. The second group included 27 patients with cystic hydatidosis diagnosed by ELISA and confirmed surgically 13 with diarrhea caused by either *E. histolytica* or *G. lamblia,* 17infected with intestinal helminths, 15 with viral hepatitis and 17 with salmonellosis. The third group consisted of 68 healthy individuals from Tehran, who had no symptoms of fascioliasis and who had a negative stool examination and ELISA test for hydatidosis and fascioliasis.

Micro-ELISA was performed on polystyrene plates coated with the E/S antigen of *Fasciola gigantica.*[@b11-asm-1-18] For the Dot-ELISA test, 1 μL of the PPF was dotted on nitrocellulose membrane discs and allowed to air dry thoroughly.[@b12-asm-1-18] The discs were placed into the well of a flat-bottom micrometer plate. Non-specific binding sites were blocked by the addition 100 μL of PBS containing 0.5% Tween 20 in each well. One hundred μL of the serum samples were diluted with PBS-Tween in a double dilution starting at 1:100, added to the discs, and the plate was incubated at room temperature for 1 hour or overnight at 4°C. The discs were washed again with PBS-Tween 20, and 100 μL of the rabbit anti-human IgG peroxidase conjugate was added to each well and the plate incubated for 2 hours. After washing, 100 μL of 0.5mg/mL DAB (diamino benzidine tetrahydrocholoride) and 0.03% H~2~O~2~ in PBS were added and incubated for 30 minutes. The serum dilution that gave visible brown spots on discs at titers 400 was considered positive. Standard formulas were used for calculation of sensitivity, specificity, percentage of positive predictive value, negative predictive value, false positive rate and false negative rate.

Results
=======

Dot-ELISA detected all positive cases at 1:200 serum dilutions, indicating 100% sensitivity and 91.72% specificity ([Table 1](#t1-asm-1-18){ref-type="table"}). At a serum dilution of 1:800 only one patient with hydatidosis showed a positive reaction. In non-fascioliasis patients and in healthy controls the minimum rate of positive reaction was observed at 1:800 and 1:400 titers, respectively. The sensitivity, specificity and other validity indices of the Dot-ELISA technique using PPF antigen for serodiagnosis of human *Fasciola* infection are shown in [Table 2](#t2-asm-1-18){ref-type="table"}. The best sensitivity and specificity (94.23% and 99.36%) was obtained at the 1:800 serum titer. Thus, for diagnosis of human fascioliasis by Dot-ELISA, the serum dilution of 1:800 can be recommended as the cut-off.

Discussion
==========

Outbreaks of acute human fascioliasis occur throughout the world.[@b13-asm-1-18]--[@b19-asm-1-18] Various techniques have been evaluated for diagnosis since clinical signs are variable and not efficient. In the early period of infection, the parasites are not sexually mature and cannot release eggs, so observation of fluke eggs in fecal examination is impossible. Ectopic location of the parasite in extra-hepatic sites may prevent a correct clinical and fecal diagnosis of fascioliasis.

Immunodiagnosis is an important adjunct to clinical findings.[@b2-asm-1-18] The need for immunodiagnostic testing for fascioliasis is much greater for humans than for their livestock.[@b2-asm-1-18] Various immunological techniques have been used in diagnosis of human and animal fascioliasis.[@b20-asm-1-18] Most workers today use ELISA and/or Western immunoblots.[@b3-asm-1-18]--[@b5-asm-1-18] The value of immunodiagnostic methods depends on the applied antigens. The antigens used for different techniques have been primarily derived from adult worm extracts or excretory/secretory products. Although the preferred antigen is an E/S product, some investigators have used partially purified fraction (PPF) for both ELISA and Dot-ELISA technique.[@b6-asm-1-18],[@b7-asm-1-18]

Using ELISA with excretory/secretory Fasciola (FhES) antigen, Espino et al.[@b21-asm-1-18] had positive results in 20 patients with confirmed fascioliasis. No cross reactivity was observed using sera from patients with other parasitic infections, including schistosomiasis. Hillyer and Soler De Galanes[@b4-asm-1-18] used a FAST-ELISA with FhES antigens and found that serum from humans with fascioliasis had an elevated antibody level for the entire 3 years that infection was monitored. Zimmerman et al.[@b22-asm-1-18] used E/S antigens of *Fasciola hepatica* for diagnosis of ovine fascioliasis by Dot-ELISA. In that study, antibodies against the antigens were consistently detected by 4 weeks after the sheep were inoculated. Morilla et al.[@b23-asm-1-18] evaluated Dot-ELISA in naturally and experimentally infected sheep using E/S antigen. The infected sheep gave very high titers, from 1:25600 to 1:204800, which was 1000 to 2000 times higher than with PHT (passive haemagglutination test) or with TIA (thin layer immunoassay). Shaheen et al.[@b6-asm-1-18] applied partially purified antigens from a species of Fasciola at 180 ng protein/dot (2 μL) and serum samples at 1:20 dilution (1 μL ) for diagnosis of human fascioliasis. The sensitivity of the assay was 100% and its specificity was 97.8%. The major cause of low specificity was human schistosomiasis, which showed cross reactivity with Fasciola infection.

In a region like the north of Iran, where human schistosomiasis is not prevalent, high specificity with Dot-ELISA can be expected using PPF antigens of Fasciola. However, cross reactivity may interfere with precise interpretation of serologic results. In our study, most cross reactivity was associated with hydatidosis. In both titres of 1:400 and 1:800, only one case of hydatidosis showed a positive reaction, while in 1:1600 the cross reactivity was null. Since serum dilution at 1:800 shows high sensitivity (94.23%) and specificity (99.36%) as well as minimum cross reactivity, we suggest it as the cut-off for this assay. The disadvantage of using a 1:400 dilution is that it has relatively more cross reactivity with other infectious agents even though it had high sensitivity and specificity. In conclusion, by applying PPF antigen in the Dot-ELISA technique, we developed a sensitive and specific method for diagnosis of human fascioliasis that is also rapid and inexpensive.
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###### 

Number and percentage of sera positive for PPF antigen in Dot-ELISA.

                                               Serum dilution                                                                     
  -------------------------------------------- ---------------- ------------- ------------ ------------ ------------ ------------ ------------
  Patients with Fasciola infection (n=104)     104 (100)        102 (98.07)   98 (94.23)   97 (93.27)   82 (78.85)   62 (59.61)   13 (12.50)
                                                                                                                                  
  Patients without Fasciola infection (n=89)   9 (10.11)        1 (1.12)      1 (1.12)     0            0            0            0
                                                                                                                                  
  Healthy control subjects (n= 68)             4 (5.88)         1 (1.47)      0            0            0            0            0

###### 

Sensitivity, specificity and other validity indices of Dot-ELISA for serodiagnosis of human fascioliasis.

                                  Serum dilution                                           
  ------------------------------- ---------------- ------- ------- ------- ------- ------- -------
  Sensitivity (%)                 100              98.07   94.23   93.27   78.85   59.61   12.5
                                                                                           
  Specificity (%)                 91.72            98.72   99.36   100     100     100     100
                                                                                           
  Positive predictive value (%)   88.89            98.07   98.99   100     100     100     100
                                                                                           
  Negative predictive value (%)   100              98.72   96.30   95.73   87.71   78.89   63.31
